Adaptin Bio (APTN) Other Accumulated Expenses (2022 - 2025)

Adaptin Bio (APTN) has 4 years of Other Accumulated Expenses data on file, last reported at $25000.0 in Q4 2025.

• For the quarter ending Q4 2025, Other Accumulated Expenses changed N/A year-over-year to $25000.0; the trailing twelve-month figure through Dec 2025 stood at $25000.0 (changed N/A YoY), and the FY2025 full-year result was $25000.0, changed N/A from the prior year.
• Other Accumulated Expenses improved to $25000.0 in Q4 2025, from $12576.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $44750.0 in Q3 2024 to a low of $10000.0 in Q4 2023.
• A 4-year average of $26296.6 and a median of $25000.0 in 2025 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses slumped 33.33% in 2023 and slumped 65.31% in 2025, its largest moves.
• Tracing APTN's Other Accumulated Expenses over 4 years: stood at $15000.0 in 2022, then sank by 33.33% to $10000.0 in 2023, then soared by 347.5% to $44750.0 in 2024, then sank by 44.13% to $25000.0 in 2025.
• Business Quant data shows APTN's Other Accumulated Expenses at $25000.0 in Q4 2025, $12576.0 in Q1 2025, and $44750.0 in Q3 2024.